Literature DB >> 22576289

Composition of fibrin glues significantly influences axial vascularization and degradation in isolation chamber model.

Andreas Arkudas1, Galyna Pryymachuk, Tobias Hoereth, Justus P Beier, Elias Polykandriotis, Oliver Bleiziffer, Heinz Gulle, Raymund E Horch, Ulrich Kneser.   

Abstract

In this study, different fibrin sealants with varying concentrations of the fibrin components were evaluated in terms of matrix degradation and vascularization in the arteriovenous loop (AVL) model of the rat. An AVL was placed in a Teflon isolation chamber filled with 500 μl fibrin gel. The matrix was composed of commercially available fibrin gels, namely Beriplast (Behring GmbH, Marburg, Germany) (group A), Evicel (Omrix Biopharmaceuticals S.A., Somerville, New Jersey, USA) (group B), Tisseel VH S/D (Baxter, Vienna, Austria) with a thrombin concentration of 4 IU/ml and a fibrinogen concentration of 80 mg/ml [Tisseel S F80 (Baxter), group C] and with an fibrinogen concentration of 20 mg/ml [Tisseel S F20 (Baxter), group D]. After 2 and 4 weeks, five constructs per group and time point were investigated using micro-computed tomography, and histological and morphometrical analysis techniques. The aprotinin, factor XIII and thrombin concentration did not affect the degree of clot degradation. An inverse relationship was found between fibrin matrix degradation and sprouting of blood vessels. By reducing the fibrinogen concentration in group D, a significantly decreased construct weight and an increased generation of vascularized connective tissue were detected. There was an inverse relationship between matrix degradation and vascularization detectable. Fibrinogen as the major matrix component showed a significant impact on the matrix properties. Alteration of fibrin gel properties might optimize formation of blood vessels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22576289     DOI: 10.1097/MBC.0b013e3283540c0f

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  6 in total

1.  Tissue Engineering of Axially Vascularized Soft-Tissue Flaps with a Poly-(ɛ-Caprolactone) Nanofiber-Hydrogel Composite.

Authors:  Dominic Henn; Kellen Chen; Katharina Fischer; Annika Rauh; Janos A Barrera; Yoo-Jin Kim; Russell A Martin; Matthias Hannig; Patricia Niedoba; Sashank K Reddy; Hai-Quan Mao; Ulrich Kneser; Geoffrey C Gurtner; Justin M Sacks; Volker J Schmidt
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-06-10       Impact factor: 4.730

2.  Evaluation of angiogenesis of bioactive glass in the arteriovenous loop model.

Authors:  Andreas Arkudas; Amelie Balzer; Gregor Buehrer; Isabel Arnold; Alexander Hoppe; Rainer Detsch; Phillipa Newby; Tobias Fey; Peter Greil; Raymund E Horch; Aldo R Boccaccini; Ulrich Kneser
Journal:  Tissue Eng Part C Methods       Date:  2013-01-16       Impact factor: 3.056

3.  The Arteriovenous (AV) Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering.

Authors:  Annika Weigand; Justus P Beier; Andreas Arkudas; Majida Al-Abboodi; Elias Polykandriotis; Raymund E Horch; Anja M Boos
Journal:  J Vis Exp       Date:  2016-11-02       Impact factor: 1.355

4.  Autologous serum improves bone formation in a primary stable silica-embedded nanohydroxyapatite bone substitute in combination with mesenchymal stem cells and rhBMP-2 in the sheep model.

Authors:  Anja M Boos; Annika Weigand; Gloria Deschler; Thomas Gerber; Andreas Arkudas; Ulrich Kneser; Raymund E Horch; Justus P Beier
Journal:  Int J Nanomedicine       Date:  2014-11-19

5.  Flow Induced Microvascular Network Formation of Therapeutic Relevant Arteriovenous (AV) Loop-Based Constructs in Response to Ionizing Radiation.

Authors:  Volker J Schmidt; Jennifer M Covi; Christoph Koepple; Johannes G Hilgert; Elias Polykandriotis; Amir K Bigdeli; Luitpold V Distel; Raymund E Horch; Ulrich Kneser
Journal:  Med Sci Monit       Date:  2017-02-15

Review 6.  Fibrin Sealant: The Only Approved Hemostat, Sealant, and Adhesive-a Laboratory and Clinical Perspective.

Authors:  William D Spotnitz
Journal:  ISRN Surg       Date:  2014-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.